8-K/A

AMENDMENT NO. 1 TO FORM 8-K

Company: ABVC BIOPHARMA, INC.
Filed: June 8, 2021
Period of Report: November 5, 2020
Accession Number: 0001213900-21-031465

View Document ↗ View on SEC.gov ↗